{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T02:44:31Z","timestamp":1787453071897,"version":"build-2736575974"},"reference-count":28,"publisher":"Europa Digital & Publishing","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["EuroIntervention"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.4244\/eijy15m07_04","type":"journal-article","created":{"date-parts":[[2016,6,20]],"date-time":"2016-06-20T06:22:11Z","timestamp":1466403731000},"page":"345-351","source":"Crossref","is-referenced-by-count":31,"title":["High-sensitivity C-reactive protein predicts 10-year cardiovascular outcome after percutaneous coronary intervention"],"prefix":"10.4244","volume":"12","author":[{"given":"Rohit M.","family":"Oemrawsingh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin M.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Martijn","family":"Akkerhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Kardys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzaffer","family":"Degertekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert-Jan","family":"van Geuns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Daemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick W.","family":"Serruys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron T.","family":"van Domburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2774","reference":[{"key":"key-20166191770-0","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword.","volume":"6","author":"Hansson GK.","year":"2006","journal-title":"Nat Rev Immunol."},{"key":"key-20166191770-1","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis.","volume":"420","author":"Libby P.","year":"2002","journal-title":"Nature."},{"key":"key-20166191770-2","first-page":"5","article-title":"Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions.","volume":"64","author":"Libby P.","year":"1991","journal-title":"Lab Invest."},{"key":"key-20166191770-3","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Inflammation in atherosclerosis: from pathophysiology to practice.","volume":"54","author":"Libby P.","year":"2009","journal-title":"J Am Coll Cardiol."},{"key":"key-20166191770-4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis--an inflammatory disease.","volume":"340","author":"Ross R.","year":"1999","journal-title":"N Engl J Med."},{"key":"key-20166191770-5","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1161\/01.CIR.0000100688.17280.E6","article-title":"Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.","volume":"108","author":"Ridker PM.","year":"2003","journal-title":"Circulation."},{"key":"key-20166191770-6","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0167-4889(91)90207-E","article-title":"Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and\/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid a (SAA) in primary cultures of human hepatocytes.","volume":"1091","author":"Yap SH.","year":"1991","journal-title":"Biochim Biophys Acta."},{"key":"key-20166191770-7","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1016\/S0735-1097(99)00348-4","article-title":"Preprocedural serum levels of c-reactive protein predict early complications and late restenosis after coronary angioplasty.","volume":"34","author":"Buffon A.","year":"1999","journal-title":"J Am Coll Cardiol."},{"key":"key-20166191770-8","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S0002-9343(03)00183-9","article-title":"Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting.","volume":"114","author":"Dibra A.","year":"2003","journal-title":"Am J Med."},{"key":"key-20166191770-9","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/S0735-1097(00)00581-7","article-title":"Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE investigators. Chimeric c7E3 antiplatelet therapy in unstable angina REfractory to standard treatment trial.","volume":"35","author":"Heeschen C.","year":"2000","journal-title":"J Am Coll Cardiol."},{"key":"key-20166191770-10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0195-668X(02)00322-6","article-title":"Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA.","volume":"24","author":"Lenderink T.","year":"2003","journal-title":"Eur Heart J."},{"key":"key-20166191770-11","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1056\/NEJM200010193431602","article-title":"Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during instability in Coronary Artery Disease.","volume":"343","author":"Lindahl B.","year":"2000","journal-title":"N Engl J Med."},{"key":"key-20166191770-12","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0735-1097(98)00136-3","article-title":"C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction.","volume":"31","author":"Morrow DA.","year":"1998","journal-title":"J Am Coll Cardiol."},{"key":"key-20166191770-13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1161\/01.CIR.0000109138.84579.FA","article-title":"Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the \u201creal world\u201d: the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry.","volume":"109","author":"Lemos PA.","year":"2004","journal-title":"Circulation."},{"key":"key-20166191770-14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.","volume":"107","author":"Pearson TA.","year":"2003","journal-title":"Circulation."},{"key":"key-20166191770-15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","article-title":"The meaning and use of the area under a receiver operating characteristic (ROC) curve.","volume":"143","author":"Hanley JA.","year":"1982","journal-title":"Radiology."},{"key":"key-20166191770-16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.","volume":"27","author":"Pencina MJ.","year":"2008","journal-title":"Stat Med."},{"key":"key-20166191770-17","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1161\/CIRCULATIONAHA.106.649939","article-title":"Prognostic significance of the Centers for Disease Control\/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease.","volume":"115","author":"Sabatine MS.","year":"2007","journal-title":"Circulation."},{"key":"key-20166191770-18","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1056\/NEJMoa0707402","article-title":"Genetically elevated C-reactive protein and ischemic vascular disease.","volume":"359","author":"Zacho J.","year":"2008","journal-title":"N Engl J Med."},{"key":"key-20166191770-19","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1136\/hrt.2009.174912","article-title":"Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: a meta-analysis of longitudinal studies.","volume":"96","author":"He LP.","year":"2010","journal-title":"Heart."},{"key":"key-20166191770-20","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.","volume":"375","author":"Kaptoge S.","year":"2010","journal-title":"Lancet."},{"key":"key-20166191770-21","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1161\/CIRCULATIONAHA.109.876763","article-title":"C-reactive protein and the risk of stent thrombosis and cardiovascular events after drug-eluting stent implantation.","volume":"120","author":"Park DW.","year":"2009","journal-title":"Circulation."},{"key":"key-20166191770-22","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1111\/j.1365-2796.2007.01862.x","article-title":"C-reactive protein, interleukin-6, secretory phospholipase A2 group IIA and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromes.","volume":"262","author":"Hartford M.","year":"2007","journal-title":"J Intern Med."},{"key":"key-20166191770-23","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.jacc.2010.06.045","article-title":"The evolving role of inflammatory biomarkers in risk assessment after stent implantation.","volume":"56","author":"Niccoli G.","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"key-20166191770-24","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1157\/13109645","article-title":"[Relationship between plasma C-reactive protein level and neointimal hyperplasia volume in patients with zotarolimus-eluting stents. Volumetric analysis by three-dimensional intracoronary ultrasound].","volume":"60","author":"Lasave LI.","year":"2007","journal-title":"Rev Esp Cardiol."},{"key":"key-20166191770-25","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.amjcard.2014.08.013","article-title":"Relation of C-reactive protein to coronary plaque characteristics on grayscale, radiofrequency intravascular ultrasound, and cardiovascular outcome in patients with acute coronary syndrome or stable angina pectoris (from the ATHEROREMO-IVUS study).","volume":"114","author":"Cheng JM.","year":"2014","journal-title":"Am J Cardiol."},{"key":"key-20166191770-26","doi-asserted-by":"publisher","first-page":"e584","DOI":"10.1161\/CIR.0b013e3182051b4c","article-title":"2010 ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines.","volume":"122","author":"Greenland P.","year":"2010","journal-title":"Circulation."},{"key":"key-20166191770-27","doi-asserted-by":"crossref","first-page":"III39","DOI":"10.1161\/01.CIR.0000131517.20177.5a","article-title":"Beneficial cardiovascular pleiotropic effects of statins.","volume":"109","author":"Davignon J.","year":"2004","journal-title":"Circulation."}],"container-title":["EuroIntervention"],"original-title":[],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T16:42:35Z","timestamp":1498322555000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.pcronline.com\/eurointervention\/100th_issue\/55"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["20140818-02"],"URL":"https:\/\/doi.org\/10.4244\/eijy15m07_04","relation":{},"ISSN":["1774-024X"],"issn-type":[{"value":"1774-024X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]}}}